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Beside the search for new plants; Plants investigated to have medicinal value for particular diseases has been 
also checked for extra pathogens and further in other  biological activities in a search for efficient and effective 
drug. In this study the in vitro antimicrobial capacity of Plumbago zeylanica L. root extracts were investigated 
against seven bacterial strains and one fungal strain. Antimicrobial activity was done   employing Agar disc 
diffusion and Minimum inhibitory concentration (MIC) was determined involving broth dilution method. The 
chloroform crude extracts as well as fractions were more potent than ethanolic extracts.  From MIC findings S. 
entritidis, S. aureus , E.coli were withdrawn from growth at  0.2mg/mL,  1mg/ml and 2mg/ml respectively. In 
addition, nine pure compounds were isolated and one (PFr8) inhibited a bit higher than the standard drugs.  
Keywords: Plumbago zeylanica L, antimicrobial activity, minimum inhibitory concentration (MIC), 
fractionation, invitro test  
 
1. Introduction  
Extensively more than 85% of deaths attribute to acute respiratory infections, diarrhoeal diseases, measles, 
AIDS, malaria, and tuberculosis.1 Of these deaths; about one-half are due to infectious diseases. 2, 3 
A study by WHO on conventional antimicrobial drugs such as benzyl pencilin, gentamicin, 
metronidazole, ampicilin, phenoxy methyl pencilin, and ciprofloxacin revealed that those drugs are no longer 
very effective due to continually emerging resistance by the pathogens. As people use antimicrobials for 
treatment of common diseases such as acute respiratory infections antibiotic, resistance is becoming a growing 
public health concern. 1 
 The species plumbago zeylanica is very known traditional medicinal plant.4 Traditionally in India, it 
has been used against fever and malaria and tumor, 5 against diarrhoea, dyspepsia, piles, and skin diseases 
including leprotic lesions. In Nepal as an antiviral medicine, in Taiwanese folk medicine for anti-Helicobacter 
activity, in Assam for family planning and birth control and permanent sterilization.6, 7, 8, 9In DR Congo and 
Gabon, the pounded root is applied to treat itch. In Zambia a root decoction with boiled milk is swallowed to 
treat inflammation in the mouth, throat, and chest. In southern Africa, a paste of the root in vinegar, milk and 
water is used to treat influenza and black water fever. Plumbago zeylanica L.root cooked with meat in soup is 
consumed in Zimbabwe as an aphrodisiac, and it also helps digestion. A root infusion is taken orally to treat 
shortness of breath. In Madagascar the roots are applied as a vesicant, while in Mauritius and Rodrigues a root 
decoction is used to treat diarrhoea and dyspepsia.8, 9, 10, 11 
Studies on crude extracts of plumbago species have shown antibacterial, antifungal activities against 
selected organisms infectious to human as well as anthelmintic, antimalarial, analegesic, anti-inflamatory and 
antioxidant activities. 10, 11, 12, 13, 14, 15, 16  
The plant is also proved to be  rich in active metabolites such as flavonoids, saponins, naphthoquinone, 
linoleic acid, terpenoids and palmitic acid. 7, 15, 16, 17, 18 
Plumbago zeylanica L. known by its local name Aftuh (in Tigrigna) and Amera (in Amharic) is a shrub 
widely distributed in the West and Northwest parts of Ethiopia at 1500–2200m above sea level. Traditionally 
local healers in Ethiopia use powdered bark, root or leaves to treat gonorrhea, syphilis, tuberculosis, rheumatic 
pain and swellings wound.19, 20  
Research works which screen plants for chemoterapautic significance in their crude extracts are much 
more times appear in the literature than those done in a fractionation system. The former ones are simple and 
cheaper. Thus, less worthed than the later ones. Plumbago zeylanica L is widely found in Asia particularly in 
China and India with medical value as antimutagenic,6 antihelicobacter pylori,7, anti inflammatory,8, 17, 21 
analegesic activity, 22 nephroprotective activity,23for cytotoxic effects,8 larvicidal ,8, 24 as inhibitor of growth,  
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invasion of homene – refractory prostate cancer.9, 25, 26 Plumbago zeylania shows higher antibacterial activity 
against  Escherichia coli, Salmonella typhi, Staphylococcus aureus  compared to standard Streptomycin12 and 
significantly higher antioxidant activity compared to the standard Quercetin. It also show antimicrobial activity 
against bacterial species such as Klebsiella pneumonia, Serratia marcescens, Bacillus Subtilis27, Proteus 
vulgaris, Pseudomonas aeruginosa12, 13  Micrococcus luteus,27 Vibrio cholera and fungal species such as, 
Curvularia lunata, Colletotrichum corchori, Candida albicans and Fusarium equisetai.13  The It has been 
serving as potent plant for 'Mich' mean allergy in the target area Tigiray, northern Ethiopia. However, the 
Plumbago zeylanica L. for infectious dieases is less known. The aim of this study is to foster the 
multidiamentional use of the plant by integrating its antimicrobial efficacy against pathogenic microorganisms. 
Besides pure compounds are isolated which could be new to the science, geographical variation is also a matter 
that can lead to different findings to those done outside Ethiopia. 
2. Materials and Methods 
2.1. Materials 
2.1.1. Chemicals and solvents 
Petrolium ether, sodium sulphate  anhydrous (Na2SO4), sodium chloride, barium sulphate(BaSO4)   
bariumchloride(BaCl2)  concentrated sulphuric acid, ammonia solution, muller hinton agar, nutrient agar, potato 
dextrose agar, nutrient broth, cyclohexane, diethyl ether, chloroform, dichloromethane, carbontetrachloride, ethyl 
acetate, acetone, methanol and ethanol. 
2.1.2. Instruments and equipments 
Electrical shaker, soxhlet extractor set up, Ultra violet – visible light source  rotary evaporator (laborata 4000, 
Heithbad bath, 230, 50/60 Hz), separatory funnel, vacuum pump, oven, incubator, autoclave and  fridge.  
2.1.3. Test organisms 
Bacteria: Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, Corno bacterium pyogenous, 
Salmonella typhimerum, Salmonella entritidis, Streptococci bovines.  
Fungi: Aspergillus niger 
2.2. Methods 
2.2.1. Plant Material collection 
Fresh Plumbago zeylanica L. roots were collected from Shire Endasslassie - in the month – June - August/ 2013. 
Plant sample was then send to Addis Ababa University for botanical identification and then Voucher specimen 
was deposited at the National Herbarium of Addis Ababa University with voucher specimen number B (003). 
2.2.2. Extraction 
Before extraction root of Plumbago zeylanica L. was shade-dried at room temperature for ten days; crushed in to 
powder using mortar and pestle and then stored in a bottle prior to use.  
The dried and powdered root material (156g) was extracted in 800ml chloroform for 36hrs at once using Soxhlet 
extraction. This was done thirteen times to obtain enough samples. Root powder of Plumbago zeylanica (238g) 
was also extracted by maceration in 1.5 liters of ethanol for three day on an electrical shaker (shake speed 220 at 
room temperature). Both the extracts were filtered using What man No1 filter paper and the filtrate was 
concentrated by rotary evaporator at room temperature and further with vacuum pump in Desiccator. 28, 29 
2.2.3. Antimicrobial activity 
2.2.3.1. Microbial test cultures and growth conditions 
Bacterial strains were maintained on Nutrient Agar (NA) petri dishes at 4 oC, while the fungus were rehersed on 
Potato Dextrose Agar (PDA) petri dishes. The fresh cultures were obtained by growing the test strains overnight 
at 37 oC for bacteria while fungi were grown at 28 oC for 48 hours. Individual colonies was then picked up and 
streaked on to another plate for further use.  
Antifungal and antibacterial in-vitro assays were done using disc diffusion. All the procedures were done 
according to Clinical Laboratory Standard Institute Standards Procedures and Quality Control as described by 
(Lalitha, 2006) and (Atlas, 1997).30  
2.2.3.2.  Media preparation 
Mueller Hinton Agar (MHA) (OXOID, UK) was used for bacteria bioassay while PDA(OXOID, UK) was used 
for fungi. MHA was prepared by dissolving 38g in 1000ml of distilled water and brought to boil to completely 
dissolve. Sterilization was achieved by autoclaving at 121 oC for 15 minutes. PDA was prepared by dissolving 
65g in 1 liter of distilled sterilized water, brought to boil to ensure complete dissolution. The media was 
autoclaved at 121oC for 15 minutes to ensure sterilization. The medias were dispensed (20ml) onto the pre-
sterilized petri dishes yielding uniform depths. They were then covered and allowed to cool and solidify at room 
temperature. Filter paper discs (6mm diameter) were prepared and sterilized by autoclaving at 121 oC for 15 
minutes.31, 32             
2.2.3.3.  Turbidity standard for inoculum preparation 
To standardize the inoculum density for a susceptibility test, a BaSO4 turbidity standard, equivalent to a 0.5 
McFarland standard was used. Two solutions were prepared in separate flasks. Solution A was made up by 
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diluting 1.75g of BaCl2.H2O to 100ml with distilled water to obtain 0.048M BaCl2. In solution B (0.36 N H2SO4) 
10ml of H2SO4 (Analar grade, sp. gr. 1.84) was made up to 100ml with distilled water. A 0.5ml aliquot of 
0.048M BaCl2 (1.175% w/v BaCl2.2H2O) was added to 99.5 ml of 0.36N H2SO4 (1% v/v) with constant stirring 
to maintain a suspension. The Barium Sulfate suspension was then transferred in 4 to 6 ml aliquots into screw-
cap tubes of the same size as those used in growing and diluting the bacterial inoculums. The tubes were tightly 
sealed and stored in the dark at room temperature. The barium sulfate turbidity standard was vigorously agitated 
on a mechanical vortex mixer before each use and inspected for a uniformly turbid appearance.30, 31   
2.2.3.4.  Preparation of crude extracts and isolated fractions for bioactivity test 
Exactly 0.2g of crude chloroform extract was dissolved in 2ml chloroform to get 100mg/ml concentration. This 
was then serially diluted to obtain 50mg/ml, 25mg/ml, 10 mg/ml and 5mg/ml concentrations. This procedure was 
repeated for ethanol extracts using ethanol as a solvent for dilution. Similar dilution procedure was applied for 
the fractions corresponding to their yield. All of the fractions were prepared in two to three fold dilutions.  
It should be clear that for those samples in which organic solvents were used for dilution, when antimicrobial test 
was done filter paper disks after impregnated in the stock solution was left to dry in flat glass (to let the solvent 
evaporated) and then it was sprayed with sterile distilled water. 
2.2.3.5.  Antimicrobial activity assay 
Agar disc diffusion method for anti bacterial and antifungal screening and broth dilution method for 
determination of minimum inhibitory concentration was applied as described else were with little modification.30 
2.2.3.5.1. Agar disc diffusion method 
Disc diffusion method was employed in the preliminary antimicrobial screening of both the crude organic 
extracts and bioassay guided isolated compounds. Test strains suspension of 0.5 McFarland was prepared from 
fresh cultures using normal saline. The plates were aseptically streaked with the test microorganism using a 
sterile swab and allowed to dry for few minutes. Sterile 6 mm diameter filter paper discs were impregnated with 
stock solutions (at concentrations 5, 10, 25, 50, to 100mg/ml). Using sterile forceps the discs were placed 
aseptically on the inoculated agar plates. The plates were then incubated for 24 hours at 37 oC for bacteria and at 
28 oC for fungi. The experiments were carried out in triplicates. Presence of a clear circular zone around the 
sample impregnated disc was used as an indicator of activity. The results (mean values, n = 3) were recorded by 
measuring zones diameter in millimeters with the help of calipers. Disc impregnated with the solvent used 
(chloroform, ethanol and mixture of ethyl acetate and n-hexane) was included as negative controls. For 
comparative purposes standard drugs gentamycin (30µg/disc) and amoxacilin (30µg/disc) for antibacterial and 
clotrymazole (40µg/disc) for antifungal were included as positive controls in the assays respectively.  31, 32  
2.2.3.5.2. Minimum inhibitory concentration (MIC) 
The extracts, which showed fsuperior antibacterial activity in the agar disc diffusion method, were subjected to 
the MIC assay. The minimum inhibitory concentration (MIC) of the extracts was determined for each of the test 
organisms in triplicates. To a 0.5 ml of varying concentrations of the extracts (20.0, 15.0, 10.0, 5.0 and 
1.0mg/ml), 2ml of nutrient broth was added (so the extracts were dilute by a factor of 5). Therefore the final 
concentrations were 4, 3, 2, 1, 0.2, and 0 mg/ml as a control), and then a loopful of the test organism previously 
adjusted to 0.5 McFarland turbidity standard32, 33, 34 for bacteria was introduced to the tubes. The procedure was 
repeated on the test organisms using the standard antibiotic (Streptomycin 500µg/mL). A tube containing 
nutrient broth only was seeded with the test organisms as described above to serve as control. Tubes containing 
bacterial cultures were then incubated at 37°C for 24h period. After incubation the tubes were then examined for 
bacterial growth by observing the turbidity present in the tubes. 33, 34   
2.2.4. Statistical analysis 
All experiments were carried out in triplicate with their mean values and standard deviations by formula. 
2.2.5. Fractionation  
2.2.5.1. Thin layer chromatography 
Samples were chromatographed on silicagel G (Precoated TLC plates (20 x 20 cm, 0.2 mm), Silicagel, 60 F254, 
MERK, Germany) using a series of solvents. Solvents in pure and in combination with other solvents were run in 
five development chambers. Rf values were calculated for each spot.   
2.2.5.2. Column chromatography 
 Approximatly1.5g of Plumbago zeylanica L root extracts was applied to a silica gel chromatography column 
(63-200µm, 102 x 525 mm, 70-230 mesh size). Elution of the column was then performed using mixtures of 
hexane/EtOAc in a series of three linear gradient steps. Step 1 consists of 100/0 to 90/10 using 1600mL and step 
2 consisting of 90/10 to 75/25 using 400 mL. While,  step 3 consist of 75/25 to 0/100 with total volume of 400 
mL. Column eluate was collected in 10-mL test tubes. Fractions were recombined based on TLC Rf values. 35 
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3. Results and Discussion 
3.1. Yield of plumbago zeylanica root powder 
Maceration with ethanol and Soxhlet extaction of the root with chloroform gave 3.31% w/w and 0.82% w/w. 
Percentage yield and the colour of the extracts was in agreement with colour description and extractive value 
given. 35Though, the yields were within the range, it was very small.  
3.2. Antimicrobial activity  
3.2.1. Chloroform crude extract  
Table 1. Antimicrobial zone of inhibition (mm) of crude chloroform extracts of Plumbago zeylanica L. 
Micro 
organisms 
Concentrations(mg/ml) Gent Amox Clotr 




S. aureus 20.67±0.26 17.33±0.47 11.66±0.13 10±0.08 8±0.55 22.23±0.76 19.59±0.59 -------- 
P. aeruginosa 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -------- 
E.coli 18.43±0.24 14.96±0.41 10.83±0.28 9.60±0.43 7.00±0.04 22.67±0.57 18±0.34 -------- 
C. 
pyogenousa 
16.01±0.11 12.68±0.18 9.40±0.14 9.35±0.24 8.33±0.30 20.06 ±0.36 19.86±0.70 -------- 
S. 
typhimerum 
17.04±0.14 11.33±0.11 6.67±0.28 7.67±0.14 6.67±0.17 20.34±0.65 19±0.87 -------- 
S. entritidis 21.49±0.26 19.04±0.15 12.7±0.09 9.83±0.25 7.33±0.16 20.01±0.95 21±0.87 -------- 




A. niger 19.50±0.21 16.00±0.42 12.00±0.15 8.02±0.04 8.00±0.06 -------- ------- 21.47±0.76 
• S. aureus = Staphylococcus aureus, P. arenoginosa = Pseudomonas aeruginosa, E. coli = Escherichia coli, 
C. pyogenous = Corno bacterium pyogenous, S. typhimerum = Salmonella typhimerum, S. entritidis = 
Salmonella entritidis, S. bovines = Streptococci bovines, A. niger = Aspergilus niger, Gent = Gentamycin 
(+ve control), Amox = Amoxycilin (+ve control), Clotr = Clotrymazole (+ve control).   
• Results were reported as mean ± Standard deviation of three replicate experiments. 
Chloroform extracts of Plumbago zeylanica L were tested against seven pathogenic bacterias and one pathogenic 
fungus at five different concentrations. The highest inhibition was recorded in Salmonella entritidis (21.49mm) 
followed by Staphylococcus aureus (20.67mm), Escherichia coli (18.43mm),  Salmonella typhimerum 
(17.04mm), Corno bacterium pyogenous (16.01mm),  Streptococci bovines (4.33mm) at 100mg/ml (Table 1). 
The species Pseudomonas aeruginosa was completely resistant at all concentrations even to the standard drugs. 
Similar results were recorded in descending concentration with insignificant diversion. However, Streptococci 
bovines was not affected at 5mg/ml. Concerning antifungal activity; Aspergilus niger was inhibited at all 
concentrations with highest activity recorded to be (19.5mm) at100mg/ml. 
Some of these findings were in agreement with similar study by Jeyachandran, R. etal.12 In the study chloroform 
extracts of Plumbago zeylanica L. showed 16.7±0.14mm zone of inhibition against Escherichia coli, 
14.3±0.04mm against Salmonella typhi. There were also variations in some data. Unlike the present findings P. 
arenoginosa had some what low sensitivity and S. aureus had lower zone of inhibition. 
3.2.1.1. Minimum Inhibitory Concentration (MIC) 
Table 2. Minimum inhibitory concentration of Plumbago zeylanica L. chloroform extract 
Microorganisms MICs of extract (mg/mL) 
S. entritidis 0.2 
S. aureus 1 
E.coli 2 
 
• Results were reported as mean ± standard deviation of three replicate experiments 
To their greater activity they show than the ethanolic extracts MIC was done for chloroform extracts only. Broth 
dilution method was used for this purpose and the microorganisms which were most susceptible to chloroform 
extracts were selected. About 0.2mg/mL was the point at which S. entritidis was withdrawn from growth. S. 
aureus was blocked from growth at 1mg/ml and E.coli was cleared in the test tube with 2mg/ml (Table 2). 
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3.2.2.  Ethanolic crude extract 
Table 3. Antimicrobial zone of inhibition of crude Ethanol extracts of Plumbago zeylanica L. 
 
• S. aureus = Staphylococcus aureus, E.coli = Escherichia coli, S. entritidis = Salmonella entritidis, A. niger 
= Aspergilus niger, Gent = Gentamycin (+ve control), Amox = Amoxycilin (+ve control), Clotr = 
Clotrymazole (+ve control).  
•  Results were reported as mean ± standard deviation of three replicate experiments. 
The microorganisms which were sensitive to chloroform extracts were selected purposely in antimicrobial 
activity test of ethanolic extracts. Unlike in the chloroform extracts, E.coli recorded the highest inhibition (13.52 
mm) followed by S. aureus (12mm) and least inhibition were observed for S. entritidis (Table 3). The sensitivity 
of A. niger was comparable with that of chloroform extracts and the standard with the highest inhibition of 
19.3mm at 100, 15.2mm at 50, 15mm at 25, 10 at 10 and 8.4 at 5mg/ml. But compared to the chloroform extracts 
the ethanolic extracts show lesser activity in the bacterial organisms. This particular finding compromise to those 
reported in sensitivity of E.coli  and S. aureus to the plant extracts but less in zone of inhibition at corresponding 
concentrations. Similarly, unlike to that report  E.coli  more sensitive than S. aureus as recorded here. 27, 36 
3.2.3. Antimicrobial activity of the fractions 
3.2.3.1. Chloroform crude extract fractions 
Table 4. Antimicrobial zone of inhibition of n hexane – ethyl acetate (F1-F7) and chloroform (F8) fractions of 
chloroform crude extracts of Plumbago zeylanica L. 
Treatment groups Concentrations(mg/ml) Microorganisms 
S. aureus E.coli S. entritidis 
PF1   100 20.27±0.52 12.06±0.92 16.54±0.31 
50 6.5±0.34 7.10±0.34 8.0±0.22 
25 0.0026 0.00±0.66 7.00±0.12 
MF2  100 18.26±0.65 26.20±0.57 20.24±0.32 
50 16.08±0.37 20.34±0.89 14.02±0.15 
25 6.53±0.46 10.29±0.46 14.92±0.24 
PF3  100 0.00 16.51±0.57 11.37±0.26 
50 0.00 16.43±0.29 11.85±0.23 
25 0.00 14.00±0.19 10.67±0.06 
MF4  100 0.00 20.04±0.26 11.50±0.06 
50 0.00 18.85±0.24 8.00±0.24 
25 0.00 14.5±0.21 7.05±0.64 
PF5  100 20.19±0.65 11.12±0.14 18.06±0.21 
50 17.22±0.48 11.25±0.16 7.36±0.35 
25 9.18±0. 24 0.00 6.69±0.26 
PF6  100 16.41±0.16 12.58±0.13 8.27±0.14 
50 12.33±0.24 11.11±0.11 8.08±0.16 
25 12.10±0.28 10.00±0.65 8.24±0.21 
PF7  100 8.73±0.46 17.00±0.57 10.28±0.35 
50 6.5±0.28 12.64±0.52 7.28±0.14 
25 6.5±0.49 8.5±0.34 0.00±0.01 
PF8  100 23.03±0.37 15.16±0.81 22.0±0.06 
50 18.29±0.25 11.55±0.48 16.49±0.21 
25 11.07±0.49 8.25±0.96 12.14±0.08 
Gentamycin 30µg/disk 22.23±0.76 22.67±0.57 20.01±0.95 
Amoxycilin 30 µg/disk 19.59±0.59 18.00±0.34 21.00±0.87 
Canamycin 30 µg/disk 18.79±0.46 19.28±0.64 21.24±0.65 
• S. aureus = Staphylococcus aureus, E.coli  = Escherichia coli, S. entritidis =  Salmonella entritidis 
• PF7= pure(P) fraction(F) Number seven(7) throughout the text 
Micro 
organisms 
Concentrations(mg/ml) Gent Amox Clotr 
100 50 25 10 5 
30µg/disk 30µg/disk 40µg/disk 
Bacterial 
strains 

















A. niger 19.3±0.24 15.2±0.14 15.00±0.25 10.00±0.42 8.40±0.22 -------- -------- 21.47±0.76 
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• MF2= mixture(M) fraction(F) Number two(2) throughout the text 
• Results were reported as mean ± standard deviation of three replicate experiments.  
The activity of Plumbago zeylanica L seems to be better in some of the individual isolated compounds than the 
crude extracts. For example, PF8 recorded 23.03mm against S. aureus and  22.00mm against S. entritidis at 
100mg/ml. Relatively the inhibition of PF1 against  S. aureus (20.27mm), S. entritidis (16.54mm);  PF3 against 
E.coli  (16.51mm); PF5  againt S. aureus, (20.19mm), S. entritidis (18.06mm); PF6 against S. aureus (16.41mm), 
P F7 against E.coli  (17.00mm) were promising. Inhibition zones were uniform in decreasing order with respect 
to decrease in concentration. Zones of inhibition were good at 25mg/ml (11.07, 8.25 and 12.14mm) in case of 
PF8  against the three microorganisms in that order. Similarly PF3 inhibited 14.00mm and 10.67mm against E. 
coli and S. entritidis respectively. PF6 inhibited -12, 10 and 8mm against S. aureus, E.coli and S. entritidis 
respectively. But low zones of inhibition were recorded for PF1 against S. entritidis (7mm) while, PF5 againt S. 
entritidis (6.69mm) and for PF7 6.50 mm against S. aureus. 
S. aureus was found to be resistant to PF1 at 25mg/ml and to PF3 at all concentrations. E. coli was resistant to 
PF1 and PF5 at 25mg/ml and S. entritidis to PF7 at 25mg/ml.  
The MF2, a mixture of two compounds, recorded highest zone of inhibition (26. 20mm) than individual 
compounds of its components and all treatment groups in this activity against E. coli. MF2 also showed better 
inhibition than its components against S. entritidis (20.24) at 100mg/ml. This was true at 50mg/ml compared to 
its individual components PF1 and PF3 . The activity of MF4 against S. aureus was totally diminished than 
individual components with null zone of inhibition at all concentrations. However, better zone of inhibition was 
observed against E. coli than its components at all concentration.  Other results were comparable except MF4 
exhibited less zone of inhibition (11.50mm) at 100mg/ml than PF5 (18.06mm) at the same concentration for S. 
entritidis (Table 4). 
3.2.3.2. Ethanolic crude extract fractions 
 Table 5. Antimicrobial zone of inhibition of n hexane – ethyl acetate (PFA- PFC) fractions of ethanolic crude 
extracts of Pumbago zeylanica L. 
Treatment groups Concentrations(mg/ml) Microorganisms 
S. aureus E.coli S. entritidis 
P FA  100 12.23±0.25 12.46±0.18 8.00±0.45 
50 8.54±0.36 11.41±0.16 7.02±0.01 
25 6.55±0.24 6.53±0..05 7.05±0.1 
PFB  100 8.85±0.11 7.13±0.03 8.72±0.32 
50 6.54±0.26 7.06±0.2 7.50±0.16 
25 6.55±0.27 6.50±0.20 7.05±0.24 
PFC  100 14.59±0.65 10.54±0.44 7.07±0.15 
50 6.53±0.48 0.00 6.05±0.13 
25 6.56±0.65 0.00 0.00 
Gentamycin 30µg/disk 22.23±0.76 22.67±0.57 22.09±0.95 
Amoxycilin 30 µg/disk 21.59±0.59 20.00±0.54 21.00±0.87 
Canamycin 30 µg/disk 18.79±0.46 19.28±0.64 21.24±0.65 
 
• S. aureus = Staphylococcus aureus, E.coli  = Escherichia coli, S. entritidis =  Salmonella entritidis 
• Results were reported as mean ± standard deviation of three replicate experiments. 
Antimicrobial activity of fractions from ethanolic crude extracts were less active than fractions of chloroform 
extracts. Here the highest inhibition observed was 14.59mm by PFC at 100mg/ml against S. aures. The next was 
12mm endorsed to PFA at 100mg/ml against S. aures and E. coli. Least inhibition (6.5mm) was observed by PFA 
and PFB at 25mg/ml against S. aures and E. coli correspondingly and by PFC against S. aures. On the other hand, 
E. coli was resistant at 50 and 25mg/ml and S. entrtidis at 25mg/ml only to PFC. 
 
4. Conclusion 
Especially for infectious diseases, there was no as an immediate remedy as plants and plant derived products in 
human history. Based on the traditional knowledge this study investigated the antimicrobial activity of  
Plumbago zeylanica L. hoping to add value for the local medicinal knowledge of the plant and better efficacy 
than those reported before. Significant zone of inhibition was recorded from both the crude as well as fractions. 
More over we have able to find out three to four fractions which showed promising results. The data we put here 
is an in vitro and for sure unless they are supported by invivo assays it will not be confidential. We also 
recommend additional works on characterization and structural elucidation of the active compounds isolated 
here.  
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